AN OUTPATIENT MEDICAL EXPULSIVE THERAPY FOR UNILATERAL SINGLE URETERIC CALCULI WITH SOADS REGIME. OUR 9 YEARS EXPERIENCE WITH 3000 PATIENTS

Dr Syed Sajjad Nazir, Dr Syed Adil Bashir, Dr Naveed Khan, Dr Tanveer Iqbal, Prof Shoukat A Jeelani, Prof Muneer Khan

Abstract


Introduction:

The most important recent advances in the managememt of ureteral calculi have been the development of medical expulsive therapy to facilitate passage of ureteral stones. Drugs like alpha 1 adrenergic blockers with or without corticosteroids along with hydration have been used to facilitate expulsion of stones.

Material & Methods :

3000 patients, from January 2008  to December 2017,  who were diagnosed to have ureteric calculi either by USG / NCCT  and presented to our OPD within first 2 days of colic were enrolled in this study. They were started with SOADS regime  which included Tab Alfa blocker ( Alfuzocin 10 mg ) once daily, Tab Drotaverine Hydrochloride 80 mg + Tab Mefenamic Acid 250 mg Twice Daily , Tab spironolactone 25 mgonce daily , Tab ofloxacin 200 mg Twice daily and Syrup Potassium magnesium citrate 2 Tsf with one glass of water three times daily with 2-3 litres of fluid for a period of 2 – 4 weeks .

Results :

 Out of 3000 pt , 2550 pts ( 85 % ) passed the stone with SOADS regime. 65 % of pt passed within 2 weeks of therapy and 20 % within 4 weeks. Stone size of 4mm, 5mm & 6 mm comprised 65 % who passed within 2 weeks and rest 20 % pts had stone size of 7mm, 8mm & 9mm. Rest of the 15 % were managed by URSL. An interesting observation was noticed that pts with obstructive stone unilaterally had increased BP of 10 mmhg both systolic and diasystolic.

Conclusion :. It is possible to facilitate explusion of ureteric calculi with SOADS  regime in patients who present within first 2 days of colic and thus avoid surgical intervention and thereby reducing the cost and lost working days.


Keywords


ureteric stone, alfuzosin, medical explusive therapy.

Full Text:

PDF

References


Yencilek F, Erturhan S, Onder C, Koyuncu H, Erol B, Sarica K.

Does Tamsulosin change the Management of proximally located Ureteric stones ?

Urological Research 2010; 38: 195-199

Sierakowski R, Finlayson B, Landes RR, Finlayson CD, Sierakowski N.

The frequency of Urolithiasis in hospital discharge diagnosis in the United States.

Invest Urol 1978; 15:438-41.

Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U.

Medical therapy to facilitate the passage of stones : What is the evidence ?

Eur Urol 2009; 56: 455-71

Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P.

Speedy elimination of ureterolithiasis in lower part of ureters with the alpha1blocker-Tamsulosin.

Int Urol Nephrol 2002; 34: 25-9.

Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, et al.

Medical therapy to facilitate urinary stone passage: a meta-analysis.

Lancet 2006 ; 368 : 1171-9.

Ueno A, Kawamura T, Ogawa A, Takayasu H.

Relation of spontaneous passage of ureteral calculi to size.

Urology 1977 ; 10 : 544-546.

Carstensen HE, Hansen TS.

Stones in the ureter.

Acta Chir Scand Suppl. 1973 ; 433 : 66-71.

Lotan Y, Gettman MT, Roehrborn CG.

Management of ureteric calculi: A cost comparison and decision making analysis.

J Urol 2002 ; 167 : 1621.

Cooper JT, Stack GM, and Cooper TM.

Intensive medical management of ureteral calculi.

Urology 2000; 56 : 575-8.

Tilakv M, Bhamare N.

Progesteron Hydrotherapy in Management of Small, Mid and Lower ureteric calculi.

International Journal of Recent Trends in Science and Technology 2012; 4:90-3.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2017 International Educational Applied Scientific Research Journal